Dong-A Receives US FDA Approval on Phase II Clinical Trial for DA-8159

Published: 2005-03-25 06:59:00
Updated: 2005-03-25 06:59:00
Dong-A Pharmaceutical said its novel medication for male erectile dysfunction (ED) treatment, under a codename DA-8159, has received an approval for Phase II clinical trial by the United States Food and Drug Administration (FDA).

With the approval, the company expects that the Phase II clinica...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.